Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McDonnell

Showing results (431-440 of 460) with videos related to

Pageof 46
Sort By:
Molecular Plant|February 9, 2011
Perturbation of wood cellulose synthesis causes pleiotropic effects in transgenic aspenChandrashekhar P Joshi, Shivegowda Thammannagowda, Takeshi Fujino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Mutagenesis within human FcepsilonRIalpha differentially affects human and murine IgE bindingGraham A Mackay, Mark D Hulett, Justin P D Cook, et al.
Nutrition & Metabolism|September 4, 2023
The impact of macrosomia on cardiometabolic health in preteens: findings from the ROLO longitudinal birth cohort studySophie Callanan, Sarah Louise Killeen, Anna Delahunt, et al.
Nature Structural & Molecular Biology|March 18, 2014
Human immunoglobulin E flexes between acutely bent and extended conformationsNyssa Drinkwater, Ben Cossins, Anthony H Keeble, et al.
Frontiers in Immunology|May 31, 2022
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive CombinationsNicola Principe, Wayne J Aston, Danika E Hope, et al.
Scientific Reports|August 3, 2018
Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibodyJiun-Bo Chen, Faruk Ramadani, Marie O Y Pang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaA K Nowak, A M Cook, A M McDonnell, et al.
The Journal of Biological Chemistry|April 26, 2017
Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumabAnna M Davies, Elizabeth G Allan, Anthony H Keeble, et al.
Plos One|August 5, 2021
A critical evaluation for validation of composite and unidimensional postoperative pain scales in horsesPaula Barreto da Rocha, Bernd Driessen, Sue M McDonnell, et al.
Journal for Immunotherapy of Cancer|September 29, 2024
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockadeNicola Principe, Amber-Lee Phung, Kofi L P Stevens, et al.
Pageof 46

Showing results (431-440 of 460) with videos related to

Sort By:
Pageof 46
Molecular Plant|February 9, 2011
Perturbation of wood cellulose synthesis causes pleiotropic effects in transgenic aspenChandrashekhar P Joshi, Shivegowda Thammannagowda, Takeshi Fujino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Mutagenesis within human FcepsilonRIalpha differentially affects human and murine IgE bindingGraham A Mackay, Mark D Hulett, Justin P D Cook, et al.
Nutrition & Metabolism|September 4, 2023
The impact of macrosomia on cardiometabolic health in preteens: findings from the ROLO longitudinal birth cohort studySophie Callanan, Sarah Louise Killeen, Anna Delahunt, et al.
Nature Structural & Molecular Biology|March 18, 2014
Human immunoglobulin E flexes between acutely bent and extended conformationsNyssa Drinkwater, Ben Cossins, Anthony H Keeble, et al.
Frontiers in Immunology|May 31, 2022
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive CombinationsNicola Principe, Wayne J Aston, Danika E Hope, et al.
Scientific Reports|August 3, 2018
Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibodyJiun-Bo Chen, Faruk Ramadani, Marie O Y Pang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaA K Nowak, A M Cook, A M McDonnell, et al.
The Journal of Biological Chemistry|April 26, 2017
Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumabAnna M Davies, Elizabeth G Allan, Anthony H Keeble, et al.
Plos One|August 5, 2021
A critical evaluation for validation of composite and unidimensional postoperative pain scales in horsesPaula Barreto da Rocha, Bernd Driessen, Sue M McDonnell, et al.
Journal for Immunotherapy of Cancer|September 29, 2024
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockadeNicola Principe, Amber-Lee Phung, Kofi L P Stevens, et al.
Pageof 46